About Suraksha Pharma Private Limited
Data last updated:
Suraksha Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the personal care and skincare products segment of the FMCG sector. It was incorporated on 08 May 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1998PTC029377. Its GSTIN is 36AAECS9774Q1Z9 (Telangana). The company holds 5 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹6.05 Cr. It is led by directors including Nageswararao Gupta Manepalli (Managing Director) and Raghva Tayaru Aswani Manepalli (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹103.85 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹1.57 Cr (net margin 1.5%) and EBITDA of ₹9.21 Cr (EBITDA margin 8.9%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 11% over five years.
The company has about 108 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
As per MCA filings, the company has open charges of ₹19.18 Cr and satisfied charges of ₹3.92 Cr on record. Court records list 21 cases involving the company, including 13 filed by the company and 8 filed against it; 9 cases are pending. The company has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹57.1 Lakh; the latest was in September 2016. Its 10 peer companies in the FMCG industry (Formulations, Personal Care and Skin Care) are compared by revenue, 5 larger and 5 smaller; the largest is Sara Exports Limited with revenue of ₹104.97 Cr. The company has 12 MSME Form 1 returns on record between 2019 and 2024, listing 1,049 overdue payments to 16 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website surakshapharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressHig 101 H.No.15 – 31 – 1, Phase – 5 D Mart Lane Kphb Colony, Hyderabad, Telangana, India – 500072
- IndustryFMCG, Personal Care & Skincare Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Suraksha Pharma Private Limited
The main business activities of Suraksha Pharma are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Suraksha Pharma Private Limited FY 2024 filings available
Suraksha Pharma Private Limited reported revenue of ₹103.85 Cr (up 24% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Suraksha Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 24% growth in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Suraksha Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹9.21 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.57 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Suraksha Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Suraksha Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Suraksha Pharma Private Limited
Suraksha Pharma Private Limited is compared with the companies closest to it by revenue in the FMCG industry (Formulations, Personal Care and Skin Care). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sara Exports Limited | ₹104.97 Cr (FY 2024) | •••• | •••• | -66.0% | •••• | New Delhi, Delhi, India |
| Suresh Pharmaceuticals Private Limited | ₹104.87 Cr (FY 2024) | •••• | •••• | 19.0% | •••• | Chennai, Tamil Nadu, India |
| Hygiene Plus Limited | ₹104.86 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Dadri, Uttar Pradesh, India |
| Modi-Mundipharma Beauty Products Private Limited | ₹104.83 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | New Delhi, Delhi, India |
| Atlas Gold Super Markets Private Limited | ₹104.42 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Kozhikode, Kerala, India |
| Suraksha Pharma Private Limited this company | ₹103.85 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Hyderabad, Telangana, India |
| Contemporary Targett Private Limited | ₹103.79 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Vadodara, Gujarat, India |
| Sirmaxo Chemicals Pvt Ltd | ₹103.62 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Mumbai, Maharashtra, India |
| Makcur Laboratories Limited | ₹103.51 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Dehgam, Gujarat, India |
| Antila Lifesciences Private Limited | ₹103.49 Cr (FY 2025) | •••• | •••• | 32.0% | •••• | Ahmedabad, Gujarat, India |
| Dr.Reddy's Holdings Limited | ₹103.46 Cr (FY 2021) | •••• | •••• | 24.0% | •••• | Telangana, India |
Peers are the five companies nearest above and the five nearest below Suraksha Pharma by revenue in the FMCG industry (Formulations, Personal Care and Skin Care), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Suraksha Pharma Private Limited
Suraksha Pharma Private Limited is audited by Visweswara Rao & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Visweswara Rao & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Suraksha Pharma Private Limited
Suraksha Pharma has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nageswararao Gupta Manepalli Also directs: Hemp Tribe Private Limited, Surax Cosmetics Private Limited, Surax Healthcare Private Limited and 4 more | Managing Director | 13 May 1998 | 28 Years 4 Months | Current |
| Raghva Tayaru Aswani Manepalli Also directs: Sumages Pharma Private Limited, MMC Health Care Limited | Whole-Time Director | 21 Feb 2019 | 7 Years 7 Months | Current |
| Padmaja Rani Manepalli Also directs: MMC Health Care Limited, Scoat Pharma Private Limited | Whole-Time Director | 01 Apr 2016 | 10 Years 6 Months | Current |
| Someswara Rao Manepalli Also directs: Hemp Tribe Private Limited, Sumages Pharma Private Limited, Surax Cosmetics Private Limited and 2 more | Whole-Time Director | 29 Sep 2006 | 20 Years 0 Months | Current |
Ownership and Shareholding of Suraksha Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Suraksha Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 May 2025 | Others | ₹2.84 Cr | Open |
| 05 Dec 2024 | Others | ₹3.38 Cr | Open |
| 11 Jul 2012 | Others | ₹12.97 Cr | Open |
| 31 Jan 2022 | Others | ₹2 Cr | Satisfied |
| 12 Mar 2007 | Punjab National Bank | ₹1.92 Cr | Satisfied |
Total charge records: 5 View all charges
Deals & Funding of Suraksha Pharma Private Limited
Suraksha Pharma Private Limited has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹57.1 Lakh; the latest was in September 2016.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2016 | Secondary share transfer | Undisclosed | Buyer: M.V.K. Nageswara Rao HUF, M Nageswara Rao Gupta HUF, M Someswara Rao HUF Seller: an individual |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: M Someswara Rao HUF, M Nageswara Rao Gupta HUF, 2 individuals |
| May 2012 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2010 | Secondary share transfer | Undisclosed | Buyer: M Nageswara Rao Gupta HUF Seller: an individual |
| Feb 2007 | Funding round | ₹57.1 Lakh | Investors: 3 individuals |
Full deal history
All 5 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Suraksha Pharma Private Limited
Suraksha Pharma Private Limited has 21 court cases on record: 13 filed by Suraksha Pharma, 8 filed against it. 9 cases are pending and 12 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 12 | 2 | 6 |
| High courts | 9 | 6 | 3 |
Cases on record (5 of 21)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Cheque dishonour complaint | Filed by the company against Layerly Pharmaceuticals Private Limited | Pending |
| Bombay High Court | Court case (COMIP) | Filed against the company by Sun Pharma Laboratories Limited | Pending |
| Bombay High Court | Court case (CRR) | Filed against the company by Sun Pharma Laboratories Limited | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Sun Pharma Laboratories Limited | Disposed |
| Bombay High Court | Court case (LPETN) | Filed against the company by Sun Pharma Laboratories Limited | Disposed |
Full case history
All 21 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Suraksha Pharma Private Limited
Suraksha Pharma Private Limited has 12 MSME Form 1 returns on record between 2019 and 2024, listing 1,049 overdue payments to 16 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 16)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Pharmchem | •••• | •••• | •••• |
| Supreem Pharmaceuticals Mysore Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Orchid Packaging | •••• | •••• | •••• |
| Roorkee Research & Analytical Labs Pvt Ltd | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 12 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Suraksha Pharma Private Limited
Suraksha Pharma Private Limited has a workforce of 108 employees as of Mar 27, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Suraksha Pharma Private Limited
Suraksha Pharma has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Surax Healthcare Private Limited | U24304TG2019PTC135155 | Locked |
| Mmc Health Care Limited | U93090TN1996PLC034651 | Locked |
Showing major subsidiaries. Total: 2.
CIN History of Suraksha Pharma Private Limited
Suraksha Pharma has one previous CIN (Corporate Identification Number): U24230AP1998PTC029377. The current CIN is U24230TG1998PTC029377, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG1998PTC029377 | Current |
| U24230AP1998PTC029377 | Previous |
Recent Activity on Suraksha Pharma Private Limited
Suraksha Pharma Private Limited has 7 board changes on record since 1998: 4 appointments and 3 cessations. The latest: Raghva Tayaru Aswani Manepalli ceased to be Director on 01 Mar 2019.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Suraksha Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Suraksha Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Suraksha Pharma Private Limited
Suraksha Pharma has 5 GST registrations: 3 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECS9774Q1Z9 | Telangana | Active | 01 Jul 2017 |
| 05AAECS9774Q1ZE | Uttarakhand | Active | 01 Jul 2017 |
| 05AAECS9774Q2ZD | Uttarakhand | Active | 13 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Suraksha Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suraksha Pharma Private Limited
Suraksha Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in personal care and skincare products, within the FMCG industry. It was incorporated on 08 May 1998 (28+ years old) and is registered under CIN U24230TG1998PTC029377.
Suraksha Pharma reported revenue of ₹103.85 Cr for FY 2025 (up 24% YoY).
Suraksha Pharma has 4 current directors:
- Nageswararao Gupta Manepalli - Managing Director
- Raghva Tayaru Aswani Manepalli - Whole-Time Director
- Padmaja Rani Manepalli - Whole-Time Director
- Someswara Rao Manepalli - Whole-Time Director
Suraksha Pharma reported a net profit of ₹1.57 Cr (net margin 1.5%) and EBITDA of ₹9.21 Cr (EBITDA margin 8.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Suraksha Pharma is 8% over three years and 11% over five years. In the latest year (FY 2025) revenue rose 24%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Suraksha Pharma is 36AAECS9774Q1Z9, registered in Telangana. The company has 5 GST registrations in all, of which 3 are active and 2 are cancelled or inactive. Other active GSTINs include 05AAECS9774Q1ZE (Uttarakhand), 05AAECS9774Q2ZD (Uttarakhand).
The CIN (Corporate Identification Number) of Suraksha Pharma is U24230TG1998PTC029377. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Suraksha Pharma has 21 court cases on record: 13 filed by the company and 8 filed against it. 9 are pending. Most are in the district courts.
Suraksha Pharma was incorporated on 08 May 1998, making it 28+ years old. It is registered with the Registrar of Companies, Hyderabad.
Suraksha Pharma has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹57.1 Lakh; the latest was in September 2016.
The peers of Suraksha Pharma by revenue are Sara Exports Limited, Suresh Pharmaceuticals Private Limited, Hygiene Plus Limited, Modi-Mundipharma Beauty Products Private Limited, Atlas Gold Super Markets Private Limited and 5 more, all in the FMCG industry (Formulations, Personal Care and Skin Care).
Raghva Tayaru Aswani Manepalli ceased to be Director on 01 Mar 2019. Raghva Tayaru Aswani Manepalli was appointed as Whole-Time Director on 21 Feb 2019. Someswara Rao Manepalli ceased to be Director on 15 Nov 2018. Suraksha Pharma has 7 board changes on record in total.